Benzinga · Aug 25, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Friday.
The Dow traded up 0.82% to 34,378.42 while the NASDAQ rose 0.83% to 13,575.24. The S&P 500, also rose, gaining, 0.68% to 4,406.19.
Check This Out: Top 5 Tech Stocks That May Plunge This Quarter
Leading and Lagging Sectors
Utilities shares rose by 0.7% on Friday.
In trading on Friday, communication services shares fell by 1%.
Top Headline
The University of Michigan consumer sentiment was revised lower to 69.5 in August versus a preliminary reading of 71.2.
Equities Trading UP
Affirm Holdings, Inc. (NASDAQ: AFRM) shares shot up 29% to $17.88 after the company reported better-than-expected fourth-quarter financial results and issued guidance.
Shares of YS Biopharma Co., Ltd. (NASDAQ: YS) got a boost, shooting 47% to $1.1101 after the company announced the purchase of shares by company officers. YS Biopharma announced that chairperson, Mr. Yi Zhang, and its CEO, Dr. Hui Shao, have purchased 429,188 of the company's ordinary shares at an average price of $1.407 per share, and 46,300 ordinary shares at an average price of $1.46 ...
Benzinga · Aug 25, 2023
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 100 points on Friday.
The Dow traded up 0.34% to 34,214.27 while the NASDAQ fell 0.05% to 13,456.65. The S&P 500, also rose, gaining, 0.10% to 4,380.83.
Check This Out: Top 5 Tech Stocks That Are Set To Fly This Month
Leading and Lagging Sectors
Consumer discretionary shares rose by 0.3% on Friday.
In trading on Friday, communication services shares fell by 0.5%.
Top Headline
The University of Michigan consumer sentiment was revised lower to 69.5 in August versus a preliminary reading of 71.2.
Equities Trading UP
Affirm Holdings, Inc. (NASDAQ: AFRM) shares shot up 28% to $17.69 after the company reported better-than-expected fourth-quarter financial results and issued guidance.
Shares of YS Biopharma Co., Ltd. (NASDAQ: YS) got a boost, shooting 59% to $1.20 after the company announced the purchase of shares by company officers.
Hibbett, Inc. (NASDAQ: HIBB) shares were also up, gaining 23% to $45.37 following upbeat quarterly earnings.
Equities Trading DOWN
Domo, Inc. ...
Benzinga · Aug 25, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 200 points on Friday.
Following the market opening Friday, the Dow traded up 0.69% to 34,336.37 while the NASDAQ rose 0.57% to 13,540.74. The S&P 500, also rose, gaining, 0.53% to 4,399.59.
Check This Out: Top 5 Tech Stocks That Are Set To Fly This Month
Leading and Lagging Sectors
Consumer discretionary shares rose by 0.9% on Friday.
In trading on Friday, communication services shares fell by 0.1%.
Top Headline
Hibbett Inc (NASDAQ: HIBB) reported mixed second-quarter financial results.
Hibbett reported a second-quarter FY23 sales decline of 4.6% year-on-year to $374.88 million, missing the analyst consensus of $376.11 million. EPS of $0.85 beat the analyst consensus of $0.73.
Hibbett continues to expect FY24 sales to be flat to up 2%, with EPS of $7.00 - $7.75 versus the consensus of $7.18.
Equities Trading UP
Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares shot up 59% to $1.9899 after falling over 9% on Thursday. The company, on Thursday, issued a second-quarter business update.
Shares of YS Biopharma Co., Ltd. (NASDAQ:
Benzinga · Aug 23, 2023
Gainers
BioNexus Gene Lab Corp. (NASDAQ: BGLC) shares gained 48.5% to $2.05 in pre-market trading after jumping 30% on Tuesday.
Heliogen, Inc. (NYSE: HLGN) shares surged 35.8% to $0.2866 in pre-market trading. Heliogen was granted U.S. patent #11732928 for "Receiver for Capturing Solar Energy."
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) rose 29.3% to $39.77 in pre-market trading after the company said events of retinal vasculitis in treatment with SYFOVRE were rare, with an estimated real-world rate of 0.01% per injection.
iTeos Therapeutics, Inc. (NASDAQ: ITOS) rose 23.6% to $14.52 in pre-market trading. ITeos Therapeutics recently reported a loss for the second quarter.
Arcus Biosciences, Inc. (NYSE: RCUS) shares rose 22.1% to $22.97 in pre-market trading. Arcus Biosciences recently posted downbeat quarterly results.
AIM ImmunoTech Inc. (NYSE: AIM) shares climbed 16.2% to $0.7782 in pre-market trading after gaining 9% on Tuesday. The company recently posted a narrower-than-expected quarterly loss.
WISeKey International Holding AG (NASDAQ: WKEY) shares rose 15.7% to $3.24 in pre-market trading. WISeKey International's subsidiary WISe.ART launched ...
